Trials / Completed
CompletedNCT01126554
ICG- Liver Test Versus New Biomarkers as Prognostic Markers in Critically Ill Patients
ICG- Liver Test Versus New Biomarkers as Prognostic Markers in Critically Ill
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 110 (estimated)
- Sponsor
- University of Zurich · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Comparison of ICG liver testing with copeptin and SAPS II score as prognostic markers in critically ill patients.
Detailed description
Comparison of different marker for length of stay in the ICU in critically ill patients.
Conditions
Timeline
- Start date
- 2010-07-01
- Primary completion
- 2010-12-01
- Completion
- 2011-02-01
- First posted
- 2010-05-19
- Last updated
- 2014-04-29
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT01126554. Inclusion in this directory is not an endorsement.